Viemed Healthcare (VMD) Cash & Equivalents (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.69% |
| Dec 31, 2025 | 21.38% |
| Sep 30, 2025 | -44.43% |
| Jun 30, 2025 | 97.01% |
| Mar 31, 2025 | -42.08% |
| Dec 31, 2024 | 54.58% |
| Sep 30, 2024 | 28.84% |
| Jun 30, 2024 | 20.50% |
| Mar 31, 2024 | -43.07% |
| Dec 31, 2023 | 27.40% |
| Sep 30, 2023 | -1.43% |
| Jun 30, 2023 | -56.57% |
| Mar 31, 2023 | 39.20% |
| Dec 31, 2022 | -21.25% |
| Sep 30, 2022 | -2.03% |
| Jun 30, 2022 | -25.05% |
| Mar 31, 2022 | 2.96% |
| Dec 31, 2021 | 5.74% |
| Sep 30, 2021 | -13.75% |
| Jun 30, 2021 | 0.17% |
| Mar 31, 2021 | 0.37% |
| Dec 31, 2020 | -4.37% |
| Sep 30, 2020 | 9.05% |
| Jun 30, 2020 | 253.28% |
| Mar 31, 2020 | -37.03% |
| Dec 31, 2019 | 5.74% |
| Sep 30, 2019 | 64.22% |
| Jun 30, 2019 | 3.79% |
| Mar 31, 2019 | -28.84% |
| Dec 31, 2018 | 2.35% |
| Sep 30, 2018 | 18.98% |
| Jun 30, 2018 | 84.53% |